Azithromycin Dosing for Scarlet Fever
For scarlet fever treatment, azithromycin should be dosed at 12 mg/kg once daily (maximum 500 mg) on day 1, followed by 6 mg/kg once daily (maximum 250 mg) for days 2-5. 1
Recommended Azithromycin Dosing Regimen
Children:
- Children <45 kg: 12 mg/kg on day 1, followed by 6 mg/kg for days 2-5 1
- Children >45 kg: 500 mg on day 1, followed by 250 mg for days 2-5 1
Adults:
- 500 mg on day 1, followed by 250 mg per day for days 2-5 1
First-Line Treatment Considerations
- Penicillin V remains the first-line treatment for scarlet fever (Group A Streptococcal infection) 1, 2
- Azithromycin should be reserved for patients with penicillin allergy or when compliance with a 10-day penicillin regimen is a concern 1, 3
- A complete 5-day course of azithromycin is essential to prevent treatment failure and reduce the risk of complications 3
Clinical Considerations
When to Use Azithromycin:
- Documented penicillin or beta-lactam allergy 1, 4
- Concerns about patient adherence to 10-day penicillin regimen 3
- Previous treatment failure with beta-lactam antibiotics 3
Contraindications and Precautions:
- History of hypersensitivity to any macrolide agent 1
- Caution in patients with impaired hepatic function 1
- Avoid concurrent administration with aluminum or magnesium-containing antacids (reduces absorption) 1
- Potential cardiovascular risks in patients with pre-existing cardiac conditions 1
- Monitor for drug interactions with medications metabolized by cytochrome P450 enzyme system 1
Potential Side Effects
- Gastrointestinal symptoms: abdominal discomfort, diarrhea, nausea, vomiting 1
- Headache and dizziness 1
- Rare but serious: cardiac arrhythmias, especially in patients with pre-existing cardiovascular disease 1
Treatment Efficacy
- A total dose of 60 mg/kg azithromycin (distributed over 5 days) provides effective eradication of Group A Streptococcus 3
- Treatment should begin immediately upon diagnosis to reduce the risk of complications and prevent spread of infection 2
- Identification and treatment of carriers may be valuable in outbreak settings 5